Spatially encoded biological assays

Patent metadata

Field	Value
Publication number	US-10662467-B2
Application number	US-201916276260-A
Country	US
Kind code	B2
Filing date	Feb 14, 2019
Priority date	Apr 5, 2010
Publication date	May 26, 2020
Grant date	May 26, 2020

Abstract

The present invention provides assays and assay systems for use in spatially encoded biological assays. The invention provides an assay system comprising an assay capable of high levels of multiplexing where reagents are provided to a biological sample in defined spatial patterns; instrumentation capable of controlled delivery of reagents according to the spatial patterns; and a decoding scheme providing a readout that is digital in nature.

First claim

I claim:

1. A method of associating presence or abundance of a target biological molecule with a location of a tissue sample, comprising:
delivering a plurality of probes to a tissue sample affixed to a support, wherein a probe of the plurality of probes comprises a protein that specifically binds a target biological molecule of the tissue sample, wherein the protein is conjugated to an oligonucleotide having a sequence, and
separating the probe specifically bound to the target biological molecule at the location of the tissue sample from the plurality of probes not specifically bound to the target biological molecule at the location of the tissue sample; and
sequencing all or a portion of the sequence of the oligonucleotide or a complement thereof, from the specifically bound probe, and using the determined sequence to associate presence or abundance of the target biological molecule with the location of the tissue sample.

2. The method of claim 1 , wherein two or more probes of the plurality of probes specifically bind to unique target biological molecules of the tissue sample.

3. The method of claim 2 , wherein the sequences of the oligonucleotides of the two or more probes are determined in parallel.

4. The method of claim 2 , wherein the determined sequences of the two or more probes are used to associate the presence of greater than 75 unique target biological molecules with the location of the tissue sample.

5. The method of claim 2 , wherein the determined sequences of the two or more probes are used to associate the presence or abundance or both, of the unique target biological molecules with the location of the tissue sample sequentially.

6. The method of claim 5 , wherein the unique target biological molecules comprise at least one protein and at least one nucleic acid.

7. The method of claim 2 , wherein the determined sequences of the two or more probes are used to associate the presence or abundance or both, of the unique target biological molecules with the location of the tissue sample in parallel.

8. The method of claim 2 , wherein the sequences of the oligonucleotides of the two or more probes are determined sequentially.

9. The method of claim 2 , wherein the determined sequences of the two or more probes are used to associate the presence of greater than 100 unique target biological molecules with the location of the tissue sample.

10. The method of claim 2 , wherein the determined sequences of the two or more probes are used to associate the presence of greater than 150 unique target biological molecules with the location of the tissue sample.

11. The method of claim 2 , wherein the determined sequences of the two or more probes are used to associate the presence of greater than 500 unique target biological molecules with the location of the tissue sample.

12. The method of claim 1 , wherein the target biological molecule comprises a nucleic acid.

13. The method of claim 1 , wherein the target biological molecule comprises a protein.

14. The method of claim 1 , wherein the target biological molecule is present in a subcellular target.

15. The method of claim 14 , wherein the subcellular target comprises a mitochondrion or a nucleus.

16. The method of claim 1 , wherein the plurality of probes is delivered to multiple sites of the tissue sample.

17. The method of claim 16 , wherein the multiple sites are determined by histological features of the tissue sample.

18. The method of claim 16 , wherein the method further comprises detecting differential expression of the target biological molecule in the multiple sites of the tissue sample.

19. The method of claim 18 , wherein the differential expression of the target biological molecule is associated with a biological structure or cell type in the multiple sites of the tissue sample.

20. The method of claim 1 , wherein the separating step comprises washing.

21. The method of claim 1 , wherein the tissue sample comprises a fresh-frozen or formalin fixed paraffin embedded (FFPE) tissue sample.

22. The method of claim 1 , wherein the determined sequence is used to associate abundance of the target biological molecule with the location of the tissue sample.

23. The method of claim 1 , further comprising identifying a location of the target biological molecule in one or more serial sections of the tissue sample.

24. The method of claim 23 , further comprising generating a 3-dimensional map of the target biological molecule in the tissue sample.

25. The method of claim 1 , wherein the determined sequence is used to associate the presence of the target biological molecule with the location of the tissue sample.

26. The method of claim 1 , further comprising determining activity of the target biological molecule at the location of the tissue sample.

27. The method of claim 1 , wherein the determined sequence is used to associate the presence and abundance of the target biological molecule with the location of the tissue sample.

28. The method of claim 1 , wherein the probe comprises an antibody that specifically binds a target biological molecule of the tissue sample.

29. The method of claim 1 , wherein the tissue sample is at least one tissue section.

30. The method of claim 29 , wherein the location of the target biological molecule is within the at least one tissue section.

Assignees

• Prognosys Biosciences Inc

Inventors

• Chee Mark S

Classifications

• C12Q1/6869

  Methods for sequencing · CPC title

• C12Q1/6809 Primary

  Methods for determination or identification of nucleic acids involving differential detection · CPC title

• C12Q1/6837 Primary

  using probe arrays or probe chips (C12Q1/6874 takes precedence) · CPC title

• C12Q1/6841

  In situ hybridisation · CPC title

• C40B60/04

  Integrated apparatus specially adapted for both screening libraries and identifying library members · CPC title